<!DOCTYPE html>
<html lang="en-US">
<head>
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
  <meta name="generator" content="Madoko, version 1.2.3" />
  <meta name="viewport" content="initial-scale=1.0" />
  <meta name="author" content="Dr. Jagdish Varma" />
  <title>COVID-19 Platelets and Serotonin</title>
  <style type="text/css"  class="link">
  /*# sourceURL=madoko.css */
  
  .madoko .toc>.tocblock .tocblock .tocblock {
    margin-left: 2.25em;
  }
  .madoko .toc>.tocblock .tocblock {
    margin-left: 1.5em;
  }
  .madoko .toc-contents>.tocblock>.tocitem {
    font-weight: bold;
  }
  .madoko .toc {
    margin-top: 1em;
  }
  .madoko p.para-continue {
    margin-bottom: 0pt;
  }
  .madoko .para-block+p {
    margin-top: 0pt;
  }
  .madoko ul.para-block, .madoko ol.para-block {
    margin-top: 0pt;
    margin-bottom: 0pt;
  }
  .madoko ul.para-end, .madoko ol.para-end {
    margin-bottom: 1em;
  }
  .madoko dl {
    margin-left: 0em;
  }
  .madoko blockquote {
    font-style: italic;
  }
  .madoko a.localref {
    text-decoration: none;
  }
  .madoko a.localref:hover {
    text-decoration: underline;
  }
  .madoko .footnotes {
    font-size: smaller;
    margin-top: 2em;
  }
  .madoko .footnotes hr {
    width: 50%;
    text-align: left;
  }
  .madoko .footnote {
    margin-left: 1em;
  }
  .madoko .footnote-before {
    margin-left: -1em;
    width: 1em;
    display: inline-block;
  }
  .madoko .align-center, .madoko .align-center>p {
    text-align: center !important;
  }
  .madoko .align-center pre {
    text-align: left;
  }
  .madoko .align-center>* {
    margin-left: auto !important;
    margin-right: auto !important;
  }
  .madoko .align-left, .madoko .align-left>p {
    text-align: left !important;
  }
  .madoko .align-left>* {
    margin-left: 0pt !important;
    margin-right: auto !important;
  }
  .madoko .align-right, .madoko .align-right>p {
    text-align: right !important;
  }
  .madoko .align-right>* {
    margin-left: auto !important;
    margin-right: 0pt !important;
  }
  .madoko .align-center>table,
  .madoko .align-left>table,
  .madoko .align-right>table {
    text-align: left !important;
  }
  .madoko .equation-before {
    float: right;
  }
  .madoko .bibitem {
    font-size: smaller;
  }
  .madoko .bibsearch {
    font-size: x-small;
    text-decoration:none;
    color: black;
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  .madoko .block, .madoko .figure, .madoko .bibitem, .madoko .equation, .madoko div.math {
    margin-top: 1ex;
    margin-bottom: 1ex;
  }
  .madoko .figure {
    padding: 0.5em;
    margin-left: 0pt;
    margin-right: 0pt;
  }
  .madoko .hidden {
    display: none;
  }
  .madoko .invisible {
    visibility: hidden;
  }
  .madoko.preview .invisible {
    visibility: visible;
    opacity: 0.5;
  }
  .madoko code.code, .madoko span.code {
    white-space: pre-wrap;
  }
  .madoko hr, hr.madoko {
    border: none;
    border-bottom: black solid 1px;
    margin-bottom: 0.5ex;
  }
  .madoko .framed>*:first-child {
    margin-top: 0pt;
  }
  .madoko .framed>*:last-child {
    margin-bottom: 0pt;
  }
  .madoko ul.list-style-type-dash {
      list-style-type: none !important;
  }
  .madoko ul.list-style-type-dash > li:before {
      content: "\2013";
      position: absolute;
      margin-left: -1em;
  }
  .madoko table.madoko {
    border-collapse: collapse;
  }
  .madoko td, .madoko th {
    padding: 0ex 0.5ex;
    margin: 0pt;
    vertical-align: top;
  }
  .madoko .cell-border-left {
    border-left: 1px solid black;
  }
  .madoko .cell-border-right {
    border-right: 1px solid black;
  }
  .madoko thead>tr:first-child>.cell-line,
  .madoko tbody:first-child>tr:first-child>.cell-line {
    border-top: 1px solid black;
    border-bottom: none;
  }
  .madoko .cell-line, .madoko .cell-double-line {
    border-bottom: 1px solid black;
    border-top: none;
  }
  .madoko .cell-double-line {
    border-top: 1px solid black;
    padding-top: 1.5px !important;
  }
  .madoko .input-mathpre .MathJax_Display {
    text-align: left !important;
  }
  .madoko div.input-mathpre {
    text-align: left;
    margin-top: 1.5ex;
    margin-bottom: 1ex;
  }
  .madoko .math-rendering {
    text-align: left;
    white-space: pre;
    color: gray;
  }
  .madoko .mathdisplay {
    text-align: center;
  }
  .madoko span.math-rendering {
    display:inline-block;
    width:8em;
    overflow-x:auto;
    font-size:70%;
  }
  .madoko span.math-rendering::-webkit-scrollbar {
    width:4px;
  }
  .madoko .pretty table {
    border-collapse: collapse;
  }
  .madoko .pretty td {
    padding: 0em;
  }
  .madoko .pretty td.empty {
    min-width: 1.5ex;
  }
  .madoko .pretty td.expander {
    width: 100em;
  }
  body.madoko, .madoko .serif {
    font-family: Cambria,"Times New Roman","Liberation Serif","Times",serif;
  }
  .madoko .sans-serif {
    font-family: "Calibri", "Optima", sans-serif;
  }
  .madoko .symbol {
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  body.madoko {
    -webkit-text-size-adjust: 100%;       
    text-rendering: optimizeLegibility;
  }
  body.madoko {
    max-width: 88ex; 
    margin: 1em auto;
    padding: 0em 2em;
  }
  body.preview.madoko {
    padding: 0em 1em;
  }
  .madoko p {
    text-align: justify;
  }
  .madoko h1, .madoko h2, .madoko h3, .madoko h4 {
    margin-top: 1.22em;
    margin-bottom: 1ex;
  }
  .madoko h1+p, .madoko h2+p, .madoko h3+p, .madoko h4+p, .madoko h5+p  {
    margin-top: 1ex;
  }
  .madoko h5, .madoko h6 {
    margin-top: 1ex;
    font-size: 1em;
  }
  .madoko h5 {
    margin-bottom: 0.5ex;
  }
  .madoko h5 + p {
    margin-top: 0.5ex;
  }
  .madoko h6 {
    margin-bottom: 0pt;
  }
  .madoko h6 + p {
    margin-top: 0pt;
  }
  .madoko pre, .madoko code, .madoko kbd, .madoko samp, .madoko tt,
  .madoko .monospace, .madoko .token-indent, .madoko .reveal pre, .madoko .reveal code, .madoko .email {
    font-family: Consolas,"Andale Mono WT","Andale Mono",Lucida Console,Monaco,monospace,monospace;
    font-size: 0.85em;
  }
  .madoko pre code, .madoko .token-indent {
    font-size: 0.95em;
  }
  .madoko pre code {
    font-family: inherit !important;
  }
  .madoko ol.linenums li {
    background-color: white;
    list-style-type: decimal;
  }
  .madoko .remote {
    background-color: #F0FFF0;
  }
  .madoko .remote + * {
    margin-top: 0pt;
  }
  @media print {
    body.madoko {
      font-size: 10pt;
    }
    @page {
      margin: 1in 1.5in;
    }
  }
  @media only screen and (max-device-width:1024px) {
    body.madoko {
      padding: 0em 0.5em;
    }
    .madoko li {
      text-align: left;
    }
  }
  
    </style>
  
  </head>
<body class="madoko">

<div class="body madoko" style="line-adjust:0">

<div class="titleblock align-center para-block" data-line="6" style="text-align:center;line-adjust:0">
<div class="titleheader align-center" data-line="6" style="text-align:center;line-adjust:0">
<div class="title para-block" data-line="6" style="font-size:xx-large;font-weight:bold;margin-bottom:0.5ex;line-adjust:0"><span data-line="6"></span>COVID-19 Platelets and Serotonin</div></div>
<div class="authors align-center" data-line="11" style="text-align:center;width:80%;line-adjust:0"><table class="authorrow columns block" data-line="11" style="margin-top:2ex;width:100%;line-adjust:0">
<tbody><tr><td class="author column" data-line="11" style="text-align:center;line-adjust:0">
<div class="authorname" data-line="11" style="font-size:large;line-adjust:0"><span data-line="11"></span>Dr. Jagdish Varma</div>
<div class="authoraddress" data-line="14" style="line-adjust:0"><span data-line="14"></span>Professor of Psychiatry, Bhaikaka University, Karamsad</div></td></tr></tbody></table></div></div><span data-line="8"></span>
<nav class="toc toc-contents"><h2 id="sec-contents" class="clearnum h1 heading-contents" data-heading-depth="1" style="display:block">Contents</h2>
<div class="tocblock tocblock1">
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-ards-and-platelets" data-toc-depth="1" data-toc-line="[1]{.heading-label}.&#8194;ARDS and Platelets" style="toctarget:sec-ards-and-platelets"><a href="#sec-ards-and-platelets" class="localref"><span class="heading-label">1</span>.&#8194;ARDS and Platelets</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-covid-19-and-platelets" data-toc-depth="1" data-toc-line="[2]{.heading-label}.&#8194;COVID-19 and Platelets" style="toctarget:sec-covid-19-and-platelets"><a href="#sec-covid-19-and-platelets" class="localref"><span class="heading-label">2</span>.&#8194;COVID-19 and Platelets</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-covid-19-ards-compared-with-other-etioligies" data-toc-depth="1" data-toc-line="[3]{.heading-label}.&#8194;COVID-19 ARDS compared with other etioligies" style="toctarget:sec-covid-19-ards-compared-with-other-etioligies"><a href="#sec-covid-19-ards-compared-with-other-etioligies" class="localref"><span class="heading-label">3</span>.&#8194;COVID-19 ARDS compared with other etioligies</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-covid-19-and-serotonin" data-toc-depth="1" data-toc-line="[4]{.heading-label}.&#8194;COVID-19 and serotonin" style="toctarget:sec-covid-19-and-serotonin"><a href="#sec-covid-19-and-serotonin" class="localref"><span class="heading-label">4</span>.&#8194;COVID-19 and serotonin</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-bottom-line" data-toc-depth="1" data-toc-line="[5]{.heading-label}.&#8194;Bottom line" style="toctarget:sec-bottom-line"><a href="#sec-bottom-line" class="localref"><span class="heading-label">5</span>.&#8194;Bottom line</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-references" data-toc-depth="1" data-toc-line="[6]{.heading-label}.&#8194;References" style="toctarget:sec-references"><a href="#sec-references" class="localref"><span class="heading-label">6</span>.&#8194;References</a></div></div></nav><h2 id="sec-ards-and-platelets" class="h1" data-line="10" data-heading-depth="1" style="display:block"><span data-line="10"></span><span class="heading-before"><span class="heading-label">1</span>.&#8194;</span><span data-line="10"></span>ARDS and Platelets</h2>
<p class="p noindent" data-line="12"><span data-line="12"></span>Prior studies suggest that in ARDS, platelets may exhibit a dysregulated state that exacerbates lung injury.
</p><h2 id="sec-covid-19-and-platelets" class="h1" data-line="14" data-heading-depth="1" style="display:block"><span data-line="14"></span><span class="heading-before"><span class="heading-label">2</span>.&#8194;</span><span data-line="14"></span>COVID-19 and Platelets</h2>
<p class="p noindent" data-line="16"><span data-line="16"></span>Multiple groups have reported dramatically increased platelet activation, platelet reactivity, and platelet-leukocyte aggregates in COVID-19. In addition,
plasma from patients with severe COVID-19 increased the ex vivo activation of platelets and monocytes from healthy controls.
</p>
<p class="p indent" data-line="19"><span data-line="19"></span>Patients with severe COVID-19 have been shown to harbor a higher degree of platelet activation and platelet-monocyte aggregation compared with patients
with COVID-19 that were not severe.
</p><h2 id="sec-covid-19-ards-compared-with-other-etioligies" class="h1" data-line="22" data-heading-depth="1" style="display:block"><span data-line="22"></span><span class="heading-before"><span class="heading-label">3</span>.&#8194;</span><span data-line="22"></span>COVID-19 ARDS compared with other etioligies</h2>
<p class="p noindent" data-line="24"><span data-line="24"></span>In a cohort of patients with H1N1-influenza infection with ARDS of equal severity, patients with COVID-19 ARDS displayed a 9 times higher burden of platelet-rich microthrombi in the alveolar capillaries.
</p>
<p class="p indent" data-line="26"><span data-line="26"></span>Surrogate markers of in vivo platelet activation including plasma thromboxane B2, platelet factor 4, soluble CD40 ligand, and plasma serotonin were also significantly higher in COVID-19 patients relative to those in patients with ARDS of non-COVID-19 etiologies.
</p>
<p class="p indent" data-line="28"><span data-line="28"></span>Autopsied patients with COVID-19 demonstrated an abundance of platelet-rich thrombi in the pulmonary and systemic microvasculature despite having received anticoagulation therapy.
</p>
<p class="p indent" data-line="30"><span data-line="30"></span><strong class="strong-star2">Based on above, platelet activation appears to play a central role in propagating the prothrombotic state encountered in COVID-19 in the lungs and
systemically, and this may account for recent high-quality evidence suggesting futility with the use of therapeutic anticoagulation in severe ICU cases of COVID-19.</strong><span data-line="31"></span>
</p><h2 id="sec-covid-19-and-serotonin" class="h1" data-line="33" data-heading-depth="1" style="display:block"><span data-line="33"></span><span class="heading-before"><span class="heading-label">4</span>.&#8194;</span><span data-line="33"></span>COVID-19 and serotonin</h2>
<p class="p noindent" data-line="34"><span data-line="34"></span>Serotonin in one of the mediators released from activated platelets and 95% of the total body serotonin pool is stored within the platelet granules. A health pulmonary endothelium is required for clearance of released serotonin. This clearance may be hampered in SARS-COV-2 infection. May account for elevated plasma serotonin levels in COVID-19 patients, significanlty higher in comparision to ARDS patients of non-COVID etiologies. Plasma serotonin levels have been found to be directly proportional to disease severity.
</p>
<p class="p indent" data-line="36"><span data-line="36"></span>Serotonin (5-hydroxytryptamine, 5HT), however, is a well-established mediator of pulmonary vascular tone and of hypoxic pulmonary vasoconstriction mainly through 5HT2 receptors.
</p>
<p class="p indent" data-line="38"><span data-line="38"></span>If driven by increased plasma serotonin, then effective 5HT-2 receptor antagonism (e.g. with cyproheptadine) may prove beneficial in the often challenging respiratory management of severe COVID-19.
</p><h2 id="sec-bottom-line" class="h1" data-line="40" data-heading-depth="1" style="display:block"><span data-line="40"></span><span class="heading-before"><span class="heading-label">5</span>.&#8194;</span><span data-line="40"></span>Bottom line</h2>
<p class="p noindent" data-line="41"><span data-line="41"></span>Pathologic platelet activation and platelet-mediator release in COVID-19 may be particularly effective targets for therapeutic intervention in this disease.
</p><h2 id="sec-references" class="h1" data-line="43" data-heading-depth="1" style="display:block"><span data-line="43"></span><span class="heading-before"><span class="heading-label">6</span>.&#8194;</span><span data-line="43"></span>References</h2>
<ol class="ol compact" data-line="44">
<li class="li ol-li compact-li" data-line="44"><span data-line="44"></span><a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3800402">Preprint artilcle by Jalali et al</a><span data-line="44"></span>
</li></ol>
<span data-line=""></span></div>
</body>

</html>
